FDA clears emergency use of lab-made antibodies to treat COVID-19

FDA clears emergency use of lab-made antibodies to treat COVID-19

The agency stressed that this didn’t amount to full approval, and that there were distinct limits. There wasn’t evidence the antibodies helped already-hospitalized patients, and it might even lead to “worse clinical outcomes” for those who need high-flow oxygen or ventilators. Officials were still studying the effectiveness and safety of the treatment, the FDA said — the initial authorization came after the regulator determined that the known and likely benefits outweighed the risks.

It’s hard to completely escape the politicization of the approval when President Trump was one of the earliest recipients of the antibodies and credited them with helping his recovery. As the FDA noted, though, there aren’t any other “adequate, approved and available” options for softening COVID-19’s blow. The lab-created antibodies could help save lives until there are widely available vaccines to limit the disease’s reach.

About the author


Erin Fox

From television to the internet platform, Erin switched her journey in digital media with News Brig. She served as a journalist for popular news channels and currently contributes his experience for News Brig by writing about the tech domain.

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *

Latest News